跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,991 条关于
“SMA Europe”
全部
7,991
临床试验
2,701
药物
449
机构
619
资讯
4,222
4个月前
Novartis Receives Positive CHMP Opinion for Itvisma Gene Therapy for Spinal Muscular Atrophy
去年
Scholar Rock Appoints David L. Hallal as CEO, Strengthens Leadership Team Ahead of Apitegromab Launch for SMA
去年
FDA Accepts Scholar Rock's BLA for Apitegromab in Spinal Muscular Atrophy with Priority Review
去年
HFMSE Analysis Reveals Variability in SMA Type 2 and 3 Progression Over Four Years
去年
Evrysdi Demonstrates Significant Motor Milestone Improvement in Infants with SMA
去年
Scholar Rock Submits Apitegromab BLA to FDA for Spinal Muscular Atrophy Treatment
去年
Scholar Rock Seeks FDA Approval for Novel SMA Add-on Therapy Apitegromab
2年前
SMA Therapies Show Motor Function Improvement but Gaps Remain in Respiratory and Nutritional Outcomes
去年
Novartis' Intrathecal Zolgensma Shows Positive Phase III Results for SMA Type 2
去年
Global Metabolic Disruption Discovered in SMA Patients: N-acetylneuraminic Acid Shows Treatment Potential
第 1 页,共 423 页
上一页
下一页